Marstons Mills parents preserve their late daughter’s legacy by raising funds to fight melanoma through an annual community fundraiser, the Angel’s Masquerade Ball.
Dear MGH friends, This year has been like no other for our Mass General marathon team. We were very lucky that none of our runners or their families were physically injured from the bombings. The past weeks have been an extremely […]
Dear MGH CF Marathon Team, I have waited a few days, expecting that I would find the words. It so reminds me of my favorite Cat Stevens song “How can I tell you…. But I can’t think of right words to […]
An MGH Research Scholar Award is letting Lee Zou, PhD, pursue biomedical research into a protein that could lead to new cancer therapies and discoveries about human aging
Lori Campbell, RN, a North Carolina nurse, discovers an MGH endowed fund created more than 50 years ago in her grandfather’s memory. Impressed with Mass General, she and her husband revised the fund to include unrestricted support for neurology research.
After Greg Chastain’s mother died of pancreatic cancer in 2009, he wondered what he could do to honor her memory. Growing up, she filled their home with music and when he took an interest in music, she was his constant supporter.
For the Friends of the Mass General Cancer Center, helping to provide toys to young cancer patients like Hope Bolster is part of a long tradition of caring, involvement and philanthropic support.
For more than 30 years, the Warshaws have given to Mass General because of their personal and professional ties. More recently, they have included a bequest in their will to help MGH advance medical care in years to come.
Bruce Walker, MD, is director of the Ragon Institute at MGH, MIT and Harvard. Founded in 2009 with a $100 million commitment from Phillip (Terry) and Susan Ragon, the institute seeks to accelerate the development of an HIV/AIDS vaccine. Dr. Walker has spearheaded the creation of advanced HIV/AIDS research and treatment facilities in South Africa. Much of his research has focused on HIV patients whose immunity systems allow them to control their infections spontaneously and without medication.
Research laboratories at Massachusetts General Hospital are in the midst of a revolution and computational biology is the catalyst.